Saturday 17 October 2026
Export ADUS’s income statement to Excel — free account
Addus HomeCare Corporation
ADUS Healthcare Medical Care Facilities
Addus HomeCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 23.2% from fiscal 2024. In the quarter to June 2026, revenue grew 8.01%, EPS grew 24.2%, free cash flow grew 81.7% and total debt fell 63.6%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
115.98
0.51
−0.44%
Follow ADUS
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
34.10 | 34.89 | 47.80 | 52.74 | 56.57 | 33.40 | 34.84 | 24.28 | 29.56 | 20.61 |
Piotroski F-Score |
3 | 5 | 6 | 4 | 4 | 6 | 6 | 7 | 5 | 7 |
Altman Z-Score |
6.08 | 5.24 | 8.63 | 6.80 | 4.38 | 4.06 | 4.84 | 4.61 | 4.41 | 5.17 |
P/S ratio |
1.01 | 0.97 | 1.58 | 2.07 | 2.39 | 1.70 | 1.66 | 1.41 | 1.85 | 1.36 |
P/FCF ratio |
0.00 | 7.80 | 29.52 | 185.22 | 17.83 | 42.41 | 16.29 | 14.53 | 19.33 | 18.70 |
Altman Z″-Score (non-manufacturers) |
6.00 | 5.96 | 6.99 | 5.93 | 3.39 | 4.18 | 4.15 | 4.25 | 4.15 | 5.50 |
Beneish M-Score |
(2.07) | (3.40) | (2.45) | (1.91) | (3.11) | (2.45) | (2.71) | (2.72) | (2.56) | (2.23) |
P/Operating CF |
(12.79) | 40.34 | 95.95 | 341.34 | 50.57 | 58.39 | 64.84 | 49.63 | 204.62 | 103.33 |
P/B ratio |
2.57 | 2.33 | 3.05 | 2.82 | 3.52 | 2.56 | 2.49 | 2.11 | 2.20 | 1.79 |
Price to Tangible BV |
5.81 | 5.93 | 7.49 | 9.38 | 0.00 | 261.33 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.05 | 0.94 | 1.48 | 1.99 | 2.45 | 1.76 | 1.71 | 1.47 | 1.95 | 1.39 |
EV/EBITDA |
18.81 | 11.85 | 23.84 | 28.05 | 32.74 | 18.77 | 19.46 | 14.65 | 19.21 | 12.66 |
EV/Operating CF |
(569.24) | 7.59 | 23.03 | 107.44 | 17.15 | 38.61 | 15.49 | 13.82 | 19.34 | 17.75 |
EV/FCF |
(162.61) | 7.60 | 27.60 | 178.07 | 18.31 | 43.94 | 16.84 | 15.11 | 20.43 | 19.09 |
Quick Ratio |
2.52 | 2.67 | 2.74 | 2.99 | 1.93 | 2.60 | 1.57 | 1.24 | 1.42 | 1.56 |
Current Ratio |
2.64 | 2.83 | 2.86 | 3.08 | 2.00 | 2.76 | 1.70 | 1.38 | 1.67 | 1.80 |
Net Debt/EBITDA |
0.76 | (0.32) | (1.66) | (1.13) | 0.87 | 0.64 | 0.62 | 0.56 | 1.02 | 0.25 |
Debt/Assets |
10.88% | 15.81% | 4.97% | 9.41% | 21.83% | 23.31% | 14.05% | 12.12% | 15.46% | 8.42% |
Debt/Equity |
0.16 | 0.24 | 0.06 | 0.13 | 0.38 | 0.38 | 0.21 | 0.18 | 0.23 | 0.11 |
Asset Turnover |
1.93 | 1.70 | 1.67 | 1.32 | 1.00 | 0.94 | 1.01 | 1.08 | 0.95 | 1.00 |
Operating CF/Net income |
(0.06) | 4.41 | 2.02 | 0.48 | 3.30 | 0.88 | 2.28 | 1.80 | 1.58 | 1.16 |
Capex/Depreciation |
(0.24) | 0.01 | (0.58) | (0.41) | (0.53) | (0.30) | (0.56) | (0.63) | (0.41) | (0.44) |
Interest Coverage |
6.64 | 5.65 | 4.55 | 11.19 | 13.96 | 11.36 | 7.72 | 8.19 | 13.28 | 10.18 |
| 8.12% | 7.16% | 7.39% | 6.78% | 6.66% | 8.26% | 7.62% | 9.33% | 8.78% | 9.33% | |
| 5.85% | 4.77% | 5.30% | 5.13% | 4.33% | 4.90% | 4.88% | 6.37% | 6.04% | 6.73% | |
ROIC |
5.53% | 9.54% | 6.62% | 5.13% | 4.89% | 6.58% | 6.27% | 7.42% | 5.89% | 7.70% |
Return on Tangible Assets |
13.81% | 11.06% | 13.13% | 13.01% | 20.26% | 20.04% | 40.79% | 79.24% | 56.96% | 66.14% |
Average Days of Receivables |
106.51 | 80.14 | 69.46 | 84.21 | 63.31 | 57.82 | 48.16 | 39.82 | 38.85 | 38.92 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
19.17% | 18.05% | 20.39% | 20.64% | 22.19% | 21.91% | 22.81% | 22.18% | 22.41% | 21.57% |
Intangible Assets out of Total Assets |
0.38 | 0.39 | 0.46 | 0.52 | 0.61 | 0.60 | 0.70 | 0.74 | 0.76 | 0.76 |
Share Based Compensation of Revenue |
0.27% | 0.60% | 0.80% | 0.89% | 0.79% | 1.09% | 1.12% | 0.97% | 0.97% | 1.15% |
Graham Net Nets |
0.15 | 0.15 | 0.12 | 0.08 | (0.05) | (0.03) | (0.05) | (0.08) | (0.09) | (0.04) |
Graham Number |
18.20 | 18.85 | 26.68 | 37.79 | 39.36 | 47.95 | 50.61 | 61.78 | 73.79 | 83.95 |
Earnings Yield |
2.93% | 2.87% | 2.09% | 1.90% | 1.77% | 2.99% | 2.87% | 4.12% | 3.38% | 4.85% |
Free Cash Flow Yield |
(0.64%) | 12.82% | 3.39% | 0.54% | 5.61% | 2.36% | 6.14% | 6.88% | 5.17% | 5.35% |
Revenue per Share |
35.51 | 37.14 | 42.88 | 46.96 | 49.04 | 54.93 | 59.97 | 66.18 | 67.89 | 78.80 |
Operating CF per Share |
(0.07) | 4.60 | 2.76 | 0.87 | 7.02 | 2.51 | 6.63 | 7.02 | 6.85 | 6.18 |
Capex per Share |
(0.15) | 0.01 | (0.44) | (0.33) | (0.44) | (0.30) | (0.52) | (0.59) | (0.35) | (0.43) |
Free Cash Flow per Share |
(0.22) | 4.61 | 2.31 | 0.54 | 6.58 | 2.21 | 6.10 | 6.43 | 6.49 | 5.75 |
Cash per Share |
0.71 | 4.69 | 5.84 | 8.09 | 9.30 | 10.73 | 5.04 | 4.05 | 5.82 | 4.52 |
Shareholders Equity per Share |
13.97 | 15.37 | 22.28 | 34.42 | 33.26 | 36.50 | 39.94 | 44.18 | 57.07 | 60.12 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
13.97 | 15.37 | 22.28 | 34.42 | 33.26 | 36.50 | 39.94 | 44.18 | 57.07 | 60.12 |
Free Cash Flow |
(2.45) | 52.86 | 27.85 | 7.40 | 102.58 | 34.84 | 96.81 | 102.81 | 110.41 | 103.80 |
Working Capital |
81.39 | 100.59 | 114.51 | 181.86 | 143.80 | 206.65 | 91.66 | 54.89 | 104.51 | 120.00 |
Capital Expenditures |
(1.71) | 0.09 | (5.35) | (4.62) | (6.83) | (4.64) | (8.30) | (9.44) | (6.02) | (7.70) |
Net Current Asset Value |
58.91 | 60.28 | 96.41 | 108.23 | (86.21) | (48.90) | (81.65) | (117.73) | (181.76) | (82.51) |
EV/EBIT |
27.33 | 15.86 | 33.50 | 37.16 | 42.15 | 23.12 | 23.68 | 17.06 | 21.93 | 14.28 |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
26.23 | 16.28 | 35.83 | 38.65 | 41.03 | 22.32 | 22.91 | 16.40 | 20.76 | 13.99 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.05 | 1.14 | 0.87 | 0.93 | 0.65 | 0.83 | 0.70 | 0.62 | 0.59 | 0.71 |
Cash ROIC |
(1.29%) | 19.36% | 7.82% | 1.14% | 11.95% | 3.61% | 11.45% | 11.48% | 8.57% | 8.06% |
Accounts Receivable Turnover |
3.97 | 4.05 | 5.39 | 5.23 | 5.42 | 6.41 | 7.25 | 8.79 | 9.69 | 10.36 |
Accounts Payable Turnover |
63.81 | 52.27 | 38.72 | 29.46 | 24.85 | 27.62 | 31.43 | 29.78 | 29.22 | 43.66 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
5.56 | 8.69 | 11.76 | 15.27 | 16.07 | 11.88 | 12.38 | 13.30 | 12.72 | 6.40 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
100.98 | 105.27 | 95.92 | 124.00 | 141.17 | 134.80 | 131.23 | 120.50 | 119.19 | 137.29 |
Average Payables |
4.62 | 5.93 | 9.81 | 15.94 | 21.67 | 21.53 | 20.73 | 24.14 | 26.68 | 22.00 |
Average Assets |
207.83 | 250.78 | 309.89 | 492.42 | 764.67 | 920.08 | 942.79 | 981.21 | 1,218.53 | 1,424.97 |
Average Common Equity |
149.74 | 167.04 | 222.40 | 372.04 | 497.13 | 546.51 | 603.94 | 670.12 | 838.59 | 1,027.90 |
Columns are period end dates